|[[clinical_biochemistry_section|Home]]|[[clinical_biochemistry|]]|[[examination_procedures|]]| TSH Examination Procedure **1.Purpose of examination:** TSH assay is a Chemiluminescent Microparticle Immunoassay (CMIA) for the quantitative determination of human Thyroid Stimulating Hormone (TSH) in human serum and plasma. **2.Responsibility and Authority:** * Calibration: Technician * Quality Control: Technician * Routine operation: Technician * Overall Monitoring: Quality Manager **3.Sample Details:** * Type of Sample: Serum, Plasma * Type of container and additives: Plain without any additives * Patient Preparation: As per Primary Sample Collection Manual [[sample_collection_manual|]] * Stability: At Room temperature 18°–28°C (64°–82°F) stability ≤ 24 hours * Handling and transport: As per Primary Sample collection manual * Storage: 24 hours at 2-8° C **4.Required Equipment:** Centrifuge, Auto-Pipette, Disposable Tips, Disposable sample cups, FullyAuto Chemistry Analyzer **5.Required reagents:** * Microparticles * Conjugate * Multi Assay manual dilution * Pre trigger solution * Trigger solution * Wash-buffer **6.Reagent Handling** - Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to settle at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles - Reagent Storage and stability - Unopened reagent stable at 15-30°C until expiration date. - On board System temperature reagent is stable for 28 days - Instability or deterioration should be suspected if there are precipitates, visible signs of leakage or - contamination, turbidity, or if calibration or controls do not meet the appropriate criteria. **7.Calibration Procedure:** * ARCHITECT TSH Calibrators * Frequency: - Reagent lot change - QC out of range - After service or maintenance - Replacement in any parts of Instrument * Procedure: - Start the equipment.WDI abbotte fully.docx - Calibrators are ready to use. - Put calibrator 15-20 minutes at room temperature - Prior to use, mix the contents by inverting the vial. Do not shake the vial to prevent foam formation. - Take a 150 µl calibrator solution in to separate aliquots. - Go to the calibration and give the calibration order. - Verify calibration with at least two levels of controls - If control results fall outside acceptable ranges,root cause analysis or recalibration may be necessary. **8.Quality control Procedure:** Name: Bio Rad Level 1 ,2 & 3 Frequency: As per Quality Control Procedure **Procedure for Reconstitution of IQC** * Reconstitution of QC material with 5 ml Distilled water by using calibrated fixed volume pipette. * Leave to stand for 30 min in the dark place. * Swirl gently several times during the reconstitution period to ensure that the contents are completely dissolved. * Prior to use, mix the contents by inverting the vial. Do not shake the vial as the information of foam should be avoided. Ensure that no lyophilized material remains un-reconstituted. * Prepare aliquots of 150 µl from the reconstituted QC material. * Store these aliquots at -15° C to -20° C. * Prior to use, make sure that aliquots should be at room temperature for at least 15 min. **Procedure to run IQC** * Press Control order * Select Assay /Panel, to be run. * Select the control/s and its level/s * Give Carrier Number and Position number * Press F3 / Add order * Put respected carrier in RSH rack * Check IQC results, in case outliers call residents. **9.Principle of the procedure used for examinations:** The ARCHITECT TSH assay is an automated two-step immunoassay to determine the presence of Thyroid Stimulating Hormone (TSH) in human serum and plasma using CMIA technology with flexible assay protocols, referred to as Chemiflex. * Sample, anti-β TSH antibody coated paramagnetic microparticles and TSH Assay Diluent are combined. TSH present in the sample binds to the anti-TSH antibody coated microparticles. * After washing, anti-α TSH acridinium-labeled conjugate is added to create a reaction mixture. * Following another wash cycle, Pre-Trigger and Trigger Solutions are added to the reaction mixture. * The resulting chemiluminescent reaction is measured as relative light units (RLUs). There is a direct relationship between the amount of TSH in the sample and the RLUs detected by the ARCHITECT iSystem optics. **10.Sample Preparation:** * Required SampleVolume: 150 µl of the sample * Temperature: 37° Take 150-200µl of the sample from Primary tube to the secondary aliquot. Write the sample ID on the aliquot. **Procedure to run Patient sample** * Press Patient order * Select Assay /Panel, to be run. * Give Carrier Number and Position number * Press F3 / Add order * Put respected carrier in RSH rack **11.Performance Characteristics:** Linearity: 0.0038 μIU/mL to 100.0000 μIU/mL. The limit of detection (LOD) : ≤ 0.4 ng/dL. The limit of quantification(LOQ): 0.28 ng/dL Unit:ng/dL. **Normal and critical ranges:** **Thyrotropin (thyroid-stimulating hormone) (TSH)** ^Birth-4 d^1.0-39.0^µIU/mL^ ^2-20 wk^1.7-9.1^µIU/mL^ ^21 wk-20 y^0.7-6.4^µIU/mL^ ^21-54 y^0.4-4.2^µIU/mL^ ^55-87 y^0.5-8.9^µIU/m^L **12.Laboratory Clinical interpretation:** The common causes of High TSH Level are as follows: Hypothyroidism The common causes of LowTSH Level are as follows:Primary Hyperthyroidism **13.Interference and cross reaction:** TSH assay is designed to have a potential interference from hemoglobin, bilirubin, triglycerides and protein of ≤ 10% at the levels indicated below. ^Hemoglobin^≤ 500 mg/dL^ ^Bilirubin^≤ 20 mg/dL^ ^Triglycerides^≤ 3000 mg/dL^ ^Protein^≤ 2 g/dL and 12 g/dL^ **14.Potential source of variation:** Turn around time (TAT): Routine: 6.0 hours Urgent: 2.0 hours **15.Recording of observation**: Software backup Machine raw data **16.Storage & Disposal of waste:** Follow storage & discard procedure **17.Environmental & Safety control:** Contact with acids liberates very toxic gas. Dispose of contents / container in accordance with local regulations. **18.References:** - Tietz NW, Huang WY, Rauh DF, et al. Laboratory tests in the differential diagnosis of hyperamylasemia. Clin Chem 1986 32(2):301-307 - 6 Junge W. Troge B, Klein G, et al. Evaluation of a New Assay for Pancreatic Amylase: Performance Characteristics and Estimation of Reference Intervals Clin Biochem 1989,22 109-114 - Stuttgart/New York Georg Thieme Verlag 1991 354-361. 3 Salt WB II, Schenker S. Amylase its clinical significance: a review ofthe literature [Review] Medicine 1976,55 269-281. - 4 Steinberg WM, Goldstein SS, Davies ND, et al. Diagnostic assays in acute pancreatitis [Review]. Ann Intern Med 1985,102.576-580 |**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| ^ Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH),Bhavnagar ^^^^ ^Document No.1^**Document Name**: TSH Examination Procedure^**Unique ID**:LSSTH /BIOCHEM/ SOP-5^^ ^Issue No. : 01^Issue Date :30/04/2024^Page No.^^ ^Amend No.^ Amend Date ^Prepared by: Section Incharge^Approved & Issued by: HOD,Biochemistry^